Cellectis S.A.CLLS was a big mover last session, as its shares rose over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $17.52 to $19.71 in the past one-month time frame.
The company has seen one positive estimate revision in the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Cellectis currently carries a Zacks Rank #1 (Strong Buy), while its Earnings ESP is negative.
Cellectis S.A. Price
Another favorably ranked stock is Pharming Group NV PHGUF , sporting a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks here.
Zacks' Top Investment Ideas for Long-Term Profit
How would you like to see our best recommendations to help you find today's most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.